Skip to content

Clinical trials

Endometrial Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Endometrial Neoplasms Country / region: South Korea Clear all

82 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20071
20114
20123
20131
20152
20161
20186
20196
20208
202110
202210
20236
20248
202512
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting33
Active, not recruiting19
Completed14
Unknown status12
Terminated3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Asan Medical Center10
AstraZeneca8
Merck Sharp & Dohme LLC6
Eli Lilly and Company4
Yonsei University4
GlaxoSmithKline3
National Cancer Institute (NCI)3
Novartis Pharmaceuticals3
Daiichi Sankyo2
Eisai Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Endometrial Neoplasms82
Ovarian Neoplasms28
Uterine Cervical Neoplasms19
Breast Neoplasms15
Carcinoma, Non-Small-Cell Lung15
Stomach Neoplasms15
Colorectal Neoplasms14
Neoplasms13
Neoplasm Metastasis11
Pancreatic Neoplasms11

Trials

Showing 1 to 25 of 82. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.